Erythrodermic flare-up of psoriasis with COVID-19 infection: A report of two cases and a comprehensive review of literature focusing on the mutual effect of psoriasis and COVID-19 on each other along with the special challenges of the pandemic

被引:5
作者
Behrangi, Elham [1 ]
Sadeghzadeh-Bazargan, Afsaneh [1 ]
Salimi, Nastaran [2 ]
Shaka, Zoha [2 ,3 ]
Kazemi, Mohammad Hosein Feyz [4 ]
Goodarzi, Azadeh [1 ]
机构
[1] Iran Univ Med Sci IUMS, Sch Med, Dept Dermatol, Rasool Akram Med Complex Clin Res Dev Ctr RCRDC, Niayesh St,Sattarkhan Ave, Tehran 1445613131, Iran
[2] Iran Univ Med Sci, Sch Med, Tehran, Iran
[3] Universal Sci Educ & Res Network USERN, Network Immun Infect Malignancy & Autoimmun NIIMA, Tehran, Iran
[4] Kermanshah Univ Med Sci, Sch Med, Kermanshah, Iran
来源
CLINICAL CASE REPORTS | 2022年 / 10卷 / 04期
关键词
aggravation; biologics; case reports; corona virus; COVID-19; disease course; erythroderma; erythrodermic psoriasis; flare-up; immunomodulator; immunosuppressant; management; psoriasis; review; SARS-CoV-2; treatment; METHOTREXATE;
D O I
10.1002/ccr3.5722
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The COVID-19 pandemic has been extra challenging for patients with chronic diseases. Psoriasis is one of the chronic conditions that its treatment mostly relies on immunosuppressants. In this study, we report two cases with a long history of psoriasis that COVID-19 infection caused them to undergo erythrodermic psoriasis.
引用
收藏
页数:15
相关论文
共 52 条
[1]  
Atefi N., 2019, J RES MED SCI, V2020, P25
[2]   SARS-CoV-2 infection in a psoriatic patient treated with IL-17 inhibitor [J].
Balestri, R. ;
Rech, G. ;
Girardelli, C. R. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (08) :E357-E358
[3]   Improvement of SARS-CoV-2 symptoms following Guselkumab injection in a psoriatic patient [J].
Benhadou, F. ;
del Marmol, V. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (08) :E363-E364
[4]   Novel Coronavirus Disease (COVID-19) and Biologic Therapy for Psoriasis: Successful Recovery in Two Patients After Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) [J].
Brownstone, Nicholas D. ;
Thibodeaux, Quinn G. ;
Reddy, Vidhatha D. ;
Myers, Bridget A. ;
Chan, Stephanie Y. ;
Bhutani, Tina ;
Liao, Wilson .
DERMATOLOGY AND THERAPY, 2020, 10 (04) :881-885
[5]   Evolution of COVID-19 infection in four psoriatic patients treated with biological drugs [J].
Conti, A. ;
Lasagni, C. ;
Bigi, L. ;
Pellacani, G. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (08) :E360-E361
[6]   Transient monoarthritis and psoriatic skin lesions following COVID-19 [J].
De Stefano, Ludovico ;
Rossi, Silvia ;
Montecucco, Carlomaurizio ;
Bugatti, Serena .
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (04)
[7]   Psoriasis andCOVID-19: A narrative review with treatment considerations [J].
Elmas, Omer Faruk ;
Demirbas, Abdullah ;
Kutlu, Omer ;
Bagcier, Fatih ;
Metin, Mahmut Sami ;
Ozyurt, Kemal ;
Akdeniz, Necmettin ;
Atasoy, Mustafa ;
Tursen, Umit ;
Lotti, Torello .
DERMATOLOGIC THERAPY, 2020, 33 (06)
[8]   Complicated coronavirus disease 2019 (COVID-19) in a psoriatic patient treated with ixekizumab [J].
Facheris, Paola ;
Valenti, Mario ;
Pavia, Giulia ;
Gargiulo, Luigi ;
Narcisi, Alessandra ;
Costanzo, Antonio ;
Borroni, Riccardo G. .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (08) :E267-E268
[9]   Status of a real-life cohort of patients with moderate-to-severe plaque psoriasis treated with secukinumab and considerations on the use of biological agents in the Covid-19 era [J].
Galluzzo, Marco ;
Tofani, Lorenzo ;
Bianchi, Luca ;
Talamonti, Marina .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (08) :829-830
[10]   Guttate psoriasis secondary to COVID-19 [J].
Gananandan, Kohilan ;
Sacks, Benjamin ;
Ewing, Iain .
BMJ CASE REPORTS, 2020, 13 (08)